logo
welcome
Reuters

Reuters

US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal

Reuters
Summary
Nutrition label

75% Informative

U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal.

Novo Holdings , the investment firm that has a controlling interest in Novo Nordisk , signed a deal to buy Catalent in February .

Warren urged the Federal Trade Commission to sue to block the deal if the regulator finds it illegal.

VR Score

83

Informative language

89

Neutral language

38

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links